Novo Nordisk is hedging and building its way around a global tariff war that may threaten the Wegovy maker’s plans to expand ...

This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members ...

Producing nuclear energy on Danish soil was out of the question for decades. But with Russian aggression and a climate crisis ...

Danish pharmaceutical company Novo Nordisk increased its first-quarter revenue and profit in 2025 compared to the same period ...

Obesity drugmaker Novo Nordisk's CFO said on Wednesday he was sceptical that U.S. President Donald Trump's executive order to ...

Drugmaker Novo Nordisk expects Wegovy weight-loss drug sales in the United States to start to recover once a ban on compound ...

Danish drugmaker Novo Nordisk, known for its blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, cut its ...

BAGSVAERD, Denmark (AP) — BAGSVAERD, Denmark (AP) — Novo Nordisk A/S (NVO) on Wednesday reported first-quarter earnings of $4.09 billion. The Bagsvaerd, Denmark-based company said it had profit of 92 ...

The Royal Danish Embassy in Thailand, in collaboration with Novo Nordisk Pharma (Thailand) Ltd. ('Novo Nordisk'), organised the first Danish-Thai Obesity Policy Forum, bringing together top ...

Novo Nordisk A/S' Q1 earnings reveal strong growth in semaglutide-driven sales despite a slight revenue miss. Learn more ...

Danish pharmaceutical company Novo Nordisk increased its first-quarter revenue and profit in 2025 compared to the same period last year. The company announced on Wednesday that its earnings ...

BAGSVAERD, Denmark (AP) — BAGSVAERD, Denmark (AP) — Novo Nordisk A/S (NVO) on Wednesday reported first-quarter earnings of $4.09 billion. The Bagsvaerd, Denmark-based company said it had ...